The number of people affected by and dying from neurological disorders over the past 25 years has been increasing globally. The pace of pharmaceutical advancements has simply not kept pace with the growth in disease burden.

At Appello Pharmaceuticals, we’re working to change that. Recent advances in our understanding of the human brain have catalyzed an explosion of research that we are translating into new drugs to improve the lives of patients suffering from neurologic disease.

This can - and should - be the decade in which we realize a paradigm shift in the treatment of patients living with neurological conditions. Appello is a global leader in this effort.